A review of the cost-effectiveness of adult influenza vaccination and other preventive services

Publication date: Available online 29 May 2019Source: Preventive MedicineAuthor(s): Nazila M. Dabestani, Andrew J. Leidner, Eric E. Seiber, Hyoshin Kim, Samuel B. Graitcer, Ivo M. Foppa, Carolyn B. BridgesAbstractThe Centers for Disease Control and Prevention recommend annual influenza vaccination of persons ≥6 months old. However, in 2016–17, only 43.3% of U.S. adults reported receiving an influenza vaccination. Limited awareness about the cost-effectiveness (CE) or the economic value of influenza vaccination may contribute to low vaccination coverage. In 2017, we conducted a literature review to survey estimates of the CE of influenza vaccination of adults compared to no vaccination. We also summarized CE estimates of other common preventive interventions that are recommended for adults by the U.S. Preventive Services Task Force. Results are presented as costs in US$2015 per quality-adjusted life-year (QALY) saved. Among adults aged 18–64, the CE of influenza vaccination ranged from $8000 to $39,000 per QALY. Assessments for adults aged ≥65 yielded lower CE ratios, ranging from being cost-saving to $15,300 per QALY. Influenza vaccination was cost-saving to $85,000 per QALY for pregnant women in moderate or severe influenza seasons and $260,000 per QALY in low-incidence seasons. For other preventive interventions, CE estimates ranged from cost-saving to $170,000 per QALY saved for breast cancer screening among women aged 50–74, from cost-saving to $16,000 per QAL...
Source: Preventive Medicine - Category: International Medicine & Public Health Source Type: research